{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:06:07Z","timestamp":1787497567024,"version":"build-2736575974"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T00:00:00Z","timestamp":1736726400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["KR2291\/17\\u20131"],"award-info":[{"award-number":["KR2291\/17\\u20131"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["HE2910\/16\\u20131"],"award-info":[{"award-number":["HE2910\/16\\u20131"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005677","name":"Jos\u00e9 Carreras Leuk\u00e4mie-Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021372","name":"HW & J. Hector Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021372","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.lfs.2025.123401","type":"journal-article","created":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T02:25:53Z","timestamp":1736735153000},"page":"123401","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Pharmacologically induced proteolysis of histone deacetylase-6 attenuates influenza virus replication despite limited anti-tumor effects"],"prefix":"10.1016","volume":"363","author":[{"given":"Johannes","family":"Jungwirth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas O.","family":"Mieland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Pi\u00e9e-Staffa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tino","family":"Heimburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walburgis","family":"Brenner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Ehrhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Sippl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Henke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver H.","family":"Kr\u00e4mer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2025.123401_bb0005","article-title":"The roles of histone deacetylases and their inhibitors in Cancer therapy","volume":"8","author":"Li","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.lfs.2025.123401_bb0010","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1124\/pharmrev.122.000612","article-title":"Pharmacological modulation of the crosstalk between aberrant Janus kinase signaling and epigenetic modifiers of the histone deacetylase family to treat Cancer","volume":"75","author":"Mustafa","year":"2023","journal-title":"Pharmacol. Rev."},{"issue":"10","key":"10.1016\/j.lfs.2025.123401_bb0015","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.tips.2014.08.001","article-title":"Drugging the HDAC6-HSP90 interplay in malignant cells","volume":"35","author":"Kr\u00e4mer","year":"2014","journal-title":"Trends Pharmacol. Sci."},{"issue":"15","key":"10.1016\/j.lfs.2025.123401_bb0020","doi-asserted-by":"crossref","first-page":"4991","DOI":"10.1158\/1078-0432.CCR-04-0210","article-title":"Superior activity of the combination of histone deacetylase inhibitor LAQ824 and the FLT-3 kinase inhibitor PKC412 against human acute myelogenous leukemia cells with mutant FLT-3","volume":"10","author":"Bali","year":"2004","journal-title":"Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.lfs.2025.123401_bb0025","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1182\/blood-2008-03-143644","article-title":"HDAC6 inhibition enhances 17-AAG--mediated abrogation of hsp90 chaperone function in human leukemia cells","volume":"112","author":"Rao","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.lfs.2025.123401_bb0030","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ejmech.2018.04.046","article-title":"Design and biological evaluation of tetrahydro-beta-carboline derivatives as highly potent histone deacetylase 6 (HDAC6) inhibitors","volume":"152","author":"Leonhardt","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"5","key":"10.1016\/j.lfs.2025.123401_bb0035","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1007\/s00204-016-1878-5","article-title":"Analysis of the interplay between all-trans retinoic acid and histone deacetylase inhibitors in leukemic cells","volume":"91","author":"Noack","year":"2017","journal-title":"Arch. Toxicol."},{"issue":"2","key":"10.1016\/j.lfs.2025.123401_bb0040","first-page":"277","article-title":"Human platelet lysate as validated replacement for animal serum to assess chemosensitivity","volume":"36","author":"Pons","year":"2019","journal-title":"ALTEX"},{"issue":"8","key":"10.1016\/j.lfs.2025.123401_bb0045","doi-asserted-by":"crossref","first-page":"3454","DOI":"10.1021\/acs.jmedchem.7b01593","article-title":"Marbostat-100 defines a new class of potent and selective Antiinflammatory and Antirheumatic histone deacetylase 6 inhibitors","volume":"61","author":"Sellmer","year":"2018","journal-title":"J. Med. Chem."},{"issue":"10","key":"10.1016\/j.lfs.2025.123401_bb0050","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11101436","article-title":"HDAC3 activity is essential for human leukemic cell growth and the expression of beta-catenin, MYC, and WT1","volume":"11","author":"Beyer","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.lfs.2025.123401_bb0055","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1002\/ijc.32169","article-title":"Selective pharmacological inhibitors of HDAC6 reveal biochemical activity but functional tolerance in cancer models","volume":"145","author":"Depetter","year":"2019","journal-title":"Int. J. Cancer"},{"issue":"12","key":"10.1016\/j.lfs.2025.123401_bb0060","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20123052","article-title":"Class I-histone deacetylase (HDAC) inhibition is superior to pan-HDAC inhibition in modulating cisplatin potency in high grade serous ovarian Cancer cell lines","volume":"20","author":"Bandolik","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.lfs.2025.123401_bb0065","doi-asserted-by":"crossref","first-page":"8486","DOI":"10.1021\/acs.jmedchem.1c00420","article-title":"Development of HDAC inhibitors exhibiting therapeutic potential in T-cell prolymphocytic leukemia","volume":"64","author":"Toutah","year":"2021","journal-title":"J. Med. Chem."},{"issue":"24","key":"10.1016\/j.lfs.2025.123401_bb0070","doi-asserted-by":"crossref","first-page":"16860","DOI":"10.1021\/acs.jmedchem.2c01659","article-title":"Solid-phase synthesis of Cereblon-recruiting selective histone deacetylase 6 degraders (HDAC6 PROTACs) with Antileukemic activity","volume":"65","author":"Sinatra","year":"2022","journal-title":"J. Med. Chem."},{"issue":"5","key":"10.1016\/j.lfs.2025.123401_bb0075","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1128\/MCB.01154-06","article-title":"Mice lacking histone deacetylase 6 have hyperacetylated tubulin but are viable and develop normally","volume":"28","author":"Zhang","year":"2008","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.lfs.2025.123401_bb0080","article-title":"PROTACS: a technology with a gold rush-like atmosphere","volume":"247","author":"Wang","year":"2022","journal-title":"Eur. J. Med. Chem."},{"issue":"6208","key":"10.1016\/j.lfs.2025.123401_bb0085","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1126\/science.1257037","article-title":"Influenza a virus uses the aggresome processing machinery for host cell entry","volume":"346","author":"Banerjee","year":"2014","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.lfs.2025.123401_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.113558","article-title":"A quantitative model for virus uncoating predicts influenza a infectivity","volume":"42","author":"Artcibasova","year":"2023","journal-title":"Cell Rep."},{"issue":"7","key":"10.1016\/j.lfs.2025.123401_bb0095","doi-asserted-by":"crossref","DOI":"10.3390\/cells10071722","article-title":"How influenza virus uses host cell pathways during Uncoating","volume":"10","author":"Moreira","year":"2021","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.lfs.2025.123401_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110736","article-title":"Disrupting the HDAC6-ubiquitin interaction impairs infection by influenza and Zika virus and cellular stress pathways","volume":"39","author":"Wang","year":"2022","journal-title":"Cell Rep."},{"issue":"19","key":"10.1016\/j.lfs.2025.123401_bb0105","doi-asserted-by":"crossref","first-page":"11229","DOI":"10.1128\/JVI.00727-14","article-title":"Histone deacetylase 6 inhibits influenza a virus release by downregulating the trafficking of viral components to the plasma membrane via its substrate, acetylated microtubules","volume":"88","author":"Husain","year":"2014","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.lfs.2025.123401_bb0110","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.febslet.2010.11.023","article-title":"Enhanced acetylation of alpha-tubulin in influenza a virus infected epithelial cells","volume":"585","author":"Husain","year":"2011","journal-title":"FEBS Lett."},{"issue":"4","key":"10.1016\/j.lfs.2025.123401_bb0115","doi-asserted-by":"crossref","first-page":"429","DOI":"10.15252\/embj.201592586","article-title":"HDAC6 regulates cellular viral RNA sensing by deacetylation of RIG-I","volume":"35","author":"Choi","year":"2016","journal-title":"EMBO J."},{"issue":"4","key":"10.1016\/j.lfs.2025.123401_bb0120","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01896-18","article-title":"HDAC6 restricts influenza a virus by deacetylation of the RNA polymerase PA subunit","volume":"93","author":"Chen","year":"2019","journal-title":"J. Virol."},{"key":"10.1016\/j.lfs.2025.123401_bb0125","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/978-1-0716-2788-4_12","article-title":"Synthesis, biochemical, and cellular evaluation of HDAC6 targeting proteolysis targeting chimeras","volume":"2589","author":"Darwish","year":"2023","journal-title":"Methods Mol. Biol."},{"issue":"8","key":"10.1016\/j.lfs.2025.123401_bb0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0104233","article-title":"Hemagglutinin 222D\/G polymorphism facilitates fast intra-host evolution of pandemic (H1N1) 2009 influenza a viruses","volume":"9","author":"Seidel","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.lfs.2025.123401_bb0135","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/s12964-024-01597-8","article-title":"The protein phosphatase-2A subunit PR130 is involved in the formation of cytotoxic protein aggregates in pancreatic ductal adenocarcinoma cells","volume":"22","author":"Nguyen","year":"2024","journal-title":"Cell Commun. Signal"},{"issue":"12","key":"10.1016\/j.lfs.2025.123401_bb0140","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1038\/s41375-024-02405-5","article-title":"Selective degradation of mutant FMS-like tyrosine kinase-3 requires BIM-dependent depletion of heat shock proteins","volume":"38","author":"Halilovic","year":"2024","journal-title":"Leukemia"},{"issue":"24","key":"10.1016\/j.lfs.2025.123401_bb0145","doi-asserted-by":"crossref","first-page":"10188","DOI":"10.1021\/acs.jmedchem.7b01447","article-title":"Structure-based design and biological characterization of selective histone deacetylase 8 (HDAC8) inhibitors with anti-neuroblastoma activity","volume":"60","author":"Heimburg","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.lfs.2025.123401_bb0150","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/978-1-4939-6527-4_26","article-title":"How to distinguish between the activity of HDAC1-3 and HDAC6 with Western blot","volume":"1510","author":"Beyer","year":"2017","journal-title":"Methods Mol. Biol."},{"issue":"8","key":"10.1016\/j.lfs.2025.123401_bb0155","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1111\/bph.15014","article-title":"Proteolysis-targeting chimeras in drug development: a safety perspective","volume":"177","author":"Moreau","year":"2020","journal-title":"Br. J. Pharmacol."},{"issue":"10","key":"10.1016\/j.lfs.2025.123401_bb0160","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.trecan.2023.06.008","article-title":"Beyond gene expression: how MYC relieves transcription stress","volume":"9","author":"Papadopoulos","year":"2023","journal-title":"Trends Cancer."},{"issue":"6","key":"10.1016\/j.lfs.2025.123401_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2023.166742","article-title":"Oxidative stress-induced apoptosis and autophagy: balancing the contrary forces in spermatogenesis","volume":"1869","author":"Sharma","year":"2023","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"issue":"12","key":"10.1016\/j.lfs.2025.123401_bb0170","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/nchembio.2486","article-title":"Inhibition of USP10 induces degradation of oncogenic FLT3","volume":"13","author":"Weisberg","year":"2017","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.lfs.2025.123401_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.dnarep.2023.103613","article-title":"Positive and negative regulators of RAD51\/DMC1 in homologous recombination and DNA replication","volume":"134","author":"Ito","year":"2024","journal-title":"DNA Repair (Amst)"},{"key":"10.1016\/j.lfs.2025.123401_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116663","article-title":"H2AX: a key player in DNA damage response and a promising target for cancer therapy","volume":"175","author":"Prabhu","year":"2024","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.lfs.2025.123401_bb0185","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00204-021-03174-1","article-title":"Inhibitors of class I HDACs and of FLT3 combine synergistically against leukemia cells with mutant FLT3","volume":"96","author":"Wachholz","year":"2022","journal-title":"Arch. Toxicol."},{"issue":"40","key":"10.1016\/j.lfs.2025.123401_bb0190","doi-asserted-by":"crossref","first-page":"4560","DOI":"10.1038\/s41388-022-02450-3","article-title":"Targeting the MYC interaction network in B-cell lymphoma via histone deacetylase 6 inhibition","volume":"41","author":"Winkler","year":"2022","journal-title":"Oncogene"},{"issue":"17","key":"10.1016\/j.lfs.2025.123401_bb0195","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1101\/gad.436407","article-title":"HDAC6 controls major cell response pathways to cytotoxic accumulation of protein aggregates","volume":"21","author":"Boyault","year":"2007","journal-title":"Genes Dev."},{"issue":"8044","key":"10.1016\/j.lfs.2025.123401_bb0200","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41586-024-08248-5","article-title":"Human HDAC6 senses valine abundancy to regulate DNA damage","volume":"637","author":"Jin","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2025.123401_bb0205","article-title":"The HDAC6 inhibitor AVS100 (SS208) induces a pro-inflammatory tumor microenvironment and potentiates immunotherapy","volume":"10(46):eadp3687","author":"Kovalovsky","year":"2024","journal-title":"Sci. Adv."},{"issue":"23","key":"10.1016\/j.lfs.2025.123401_bb0210","doi-asserted-by":"crossref","first-page":"21344","DOI":"10.1021\/acs.jmedchem.4c02273","article-title":"Development of novel silicon-based hydrophobic tags (SiHyT) for targeted proteins degradation","volume":"67","author":"Ma","year":"2024","journal-title":"J. Med. Chem."},{"issue":"10","key":"10.1016\/j.lfs.2025.123401_bb0215","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1021\/acschembio.4c00191","article-title":"Extrapolating lessons from targeted protein degradation to other proximity-inducing drugs","volume":"19","author":"Winter","year":"2024","journal-title":"ACS Chem. Biol."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320525000347?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320525000347?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T13:03:49Z","timestamp":1763039029000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320525000347"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":43,"alternative-id":["S0024320525000347"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2025.123401","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacologically induced proteolysis of histone deacetylase-6 attenuates influenza virus replication despite limited anti-tumor effects","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2025.123401","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"123401"}}